NIAID Support for the Development of Phage Therapy

Time: 1:00 pm
day: Day One


  • DMID/NIAID pre-clinical services are used to explore the efficacy of bacteriophages in vivo and in vitro
  • Biopharmaceutical Products Therapeutic Development Services Task Orders are used to Craft Product Development Plans
  • DMID/NIAID genomic services are used to analyze bacteriophage genomes
  • Funding of solicited and un-solicited grants to explore and develop the therapeutic bacteriophages and their gene products.